Skip to content

BREAKING STUDY: Anomalous Amyloid Microclots Found in 100% of the COVID-19 Vaccinated

BREAKING STUDY: Anomalous Amyloid Microclots Found in 100% of the COVID-19 Vaccinated
Published:

by Nicolas Hulscher, MPH

A new peer-reviewed study has quietly revealed one of the most consequential biological findings of the pandemic era — and the authors never acknowledge it: Every single vaccinated participant in the study had fibrinolysis-resistant, ThT-positive amyloid microclots circulating in their blood.

Hidden in the supplementary tables is a demographic and biochemical pattern that completely reframes the paper:

94% of all participants were vaccinated.
100% of these vaccinated individuals had amyloid microclots — including every “healthy control.”

The condition labeled “Long COVID” occurred almost entirely in a heavily vaccinated population, without any laboratory confirmation of prior SARS-CoV-2 infection. In reality, the study is observing Long VACCINE pathology, not Long COVID.

And because the authors’ own mechanistic experiments show that purified spike protein alone produces these amyloid, fibrinolysis-resistant clots, the implications are profound.


All individuals in the study — 100% of the vaccinated — had amyloid microclots

Researchers identified microclots using Thioflavin-T (ThT), an amyloid-binding fluorogenic dye. ThT positivity was the defining criterion. A structure was only counted as a microclot if it bound ThT.

Therefore, every microclot counted in the study is, by definition, amyloidogenic.

And according to Table S11, every single vaccinated participant had amyloid microclots in multiple size ranges:

Because 83 of 88 participants (94%) were vaccinated, this means:

Every vaccinated person in the study had amyloid microclots.


“Long COVID” (Long VACCINE) patients had extreme elevations in large, pathological amyloid microclots

Small amyloid microclots were present in everyone, but the pathological burden differed sharply.

According to Table S11:

These larger, pathogenic amyloid microclots were densely packed with:


COVID-19 infection was never verified

Despite positioning the results as a hallmark of “Long COVID,” none of the participants were confirmed to have had SARS-CoV-2 infection. The study performed:

Long COVID status was assigned purely via symptoms and clinician impression. There is no evidence in the study that any participant was biologically positive for prior infection.

Thus, the clotting abnormalities cannot be attributed specifically to infection, but rather to vaccination.

The Daily News from the Art of Liberty Foundation is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.


Spike protein alone produced identical amyloid microclots

In a mechanistic experiment, the authors added purified spike protein to fibrinogen.

This single intervention produced:

The authors confirmed that Spike protein directly induces amyloid microclot formation, corroborating previous studies.


Explains prevalent white fibrous clots found in the dead

The study’s core findings — 100% amyloid microclots in vaccinated individuals and direct spike-induced amyloid fibrin formation — offer a clear mechanism for the large, rubbery white fibrous clots increasingly reported in deceased individuals since 2021.

At the 2025 Tennessee Funeral Directors Association (TFDA) convention, former USAF Major Tom Haviland conducted the first state-level survey of embalmers:

BREAKING: Tennessee Funeral Directors Association Confirms White Fibrous Clots Are Real and Prevalent

Nicolas Hulscher, MPH

·

16 jun

BREAKING: Tennessee Funeral Directors Association Confirms White Fibrous Clots Are Real and Prevalent

By Nicolas Hulscher, MPH

Read full story

Forensic analysis by Kevin W. McCairn, PhD et al shows that these postmortem clots:

These characteristics match exactly the pathological microclots described in the new study — only at a later, aggregated, end-stage form.

The progression is biologically straightforward:

  1. Spike exposure (infection or mRNA vaccination)

  2. Amyloid microclots form — present in 100% of vaccinated subjects

  3. Large, NET-rich, fibrinolysis-resistant clots accumulate (20× higher in Long vaccine patients)

  4. These merge into massive, rubbery, white fibrous intravascular clots

This new study documents the early and intermediate stages in the living; Haviland’s surveys and McCairn’s analysis reveals the final stage in the dead.


Conclusions

Although the authors frame their findings as “Long COVID,” the underlying data reveal something far more consequential:

These findings carry serious public-health implications:

And critically:

The Best “Go Paid” Deal on Substack! You Get REAL Stuff!!

Go paid at the $5 a month level, and we will send you both the PDF and e-Pub versions of Etienne’s new book: To See the Cage Is to Leave It - 25 Techniques the Few Use to Control the Many and a coupon code for 10% off anything in the https://artofliberty.org/store/.

Go paid at the $50 a year level, and we will send you a free paperback edition of Etienne’s new book: To See the Cage Is to Leave It - 25 Techniques the Few Use to Control the Many OR “Government” - The Biggest Scam in History… Exposed! OR a 64GB Liberator flash drive if you live in the US. If you are international, we will give you a $10 credit towards shipping if you agree to pay the remainder.

Support us at the $250 Founding Member Level and get a signed high-resolution hardcover of “Government” - The Biggest Scam in History... Exposed! + Liberator flash drive + a signed high-resolution hardcover of Etienne’s new book: To See the Cage Is to Leave It - 25 Techniques the Few Use to Control the Many + everything else in our “Everything Bundle” of the best in voluntaryist thought delivered domestically. International pays shipping. Our only option for signed copies besides catching Etienne @ an event.

The Daily News from the Art of Liberty Foundation is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

More in Health, Food & Pharma

See all

More from Etienne de la Boetie2

See all